[go: up one dir, main page]

MX2022010413A - Compuestos de pirrolopiridina e imidazopiridina antivirales. - Google Patents

Compuestos de pirrolopiridina e imidazopiridina antivirales.

Info

Publication number
MX2022010413A
MX2022010413A MX2022010413A MX2022010413A MX2022010413A MX 2022010413 A MX2022010413 A MX 2022010413A MX 2022010413 A MX2022010413 A MX 2022010413A MX 2022010413 A MX2022010413 A MX 2022010413A MX 2022010413 A MX2022010413 A MX 2022010413A
Authority
MX
Mexico
Prior art keywords
sup
pyrrolopyridine
imidazopyridine
antiviral compounds
compounds
Prior art date
Application number
MX2022010413A
Other languages
English (en)
Inventor
Nesya Goris
Eleonora Kiss
Robert Vrancken
Original Assignee
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leuven Kath filed Critical Univ Leuven Kath
Publication of MX2022010413A publication Critical patent/MX2022010413A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a un compuesto de la fórmula (I) o un estereoisómero, o tautómero, (ver Fórmula) (I) en la cual A1, A2, R1 y R2, tienen el mismo significado que el definido en las reivindicaciones y la descripción. La presente invención también se refiere a composiciones, en particular farmacéuticas, que comprenden dichos compuestos, y a usos de dichos compuestos y composiciones para la prevención y/o tratamiento de una infección causada por pestivirus en un animal.
MX2022010413A 2020-02-24 2021-02-24 Compuestos de pirrolopiridina e imidazopiridina antivirales. MX2022010413A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20158958 2020-02-24
PCT/EP2021/054486 WO2021170600A1 (en) 2020-02-24 2021-02-24 Pyrrolopyridine and imidazopyridine antiviral compounds

Publications (1)

Publication Number Publication Date
MX2022010413A true MX2022010413A (es) 2022-09-07

Family

ID=69810569

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010413A MX2022010413A (es) 2020-02-24 2021-02-24 Compuestos de pirrolopiridina e imidazopiridina antivirales.

Country Status (9)

Country Link
US (1) US20230130598A1 (es)
EP (1) EP4110777A1 (es)
JP (1) JP2023514443A (es)
CN (1) CN115175909A (es)
AR (1) AR121403A1 (es)
AU (1) AU2021225333A1 (es)
BR (1) BR112022016733A2 (es)
MX (1) MX2022010413A (es)
WO (1) WO2021170600A1 (es)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US6043358A (en) 1995-11-01 2000-03-28 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
AU2010299A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
HUP0101598A3 (en) 1997-12-24 2002-08-28 Vertex Pharmaceuticals Inc Cam Prodrugs of aspartyl protease inhibitors and medicaments containing them
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
GB0215293D0 (en) * 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
EP2161273B1 (en) * 2003-12-22 2015-04-15 K.U.Leuven Research & Development Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
CN1902198A (zh) * 2003-12-22 2007-01-24 鲁汶天主教大学研究开发部 咪唑并[4,5－c]吡啶化合物和抗病毒治疗的方法
WO2007034277A1 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists
SI2094702T1 (sl) * 2006-12-14 2016-03-31 Gilead Sciences, Inc. Virusni inhibitorji
JP5263205B2 (ja) * 2010-03-19 2013-08-14 富士通株式会社 光変調装置及び光変調方法
CN110229150B (zh) * 2018-03-06 2022-03-01 沈阳药科大学 咪唑并[4,5-c]吡啶类衍生物及其用途

Also Published As

Publication number Publication date
AU2021225333A1 (en) 2022-08-11
CN115175909A (zh) 2022-10-11
WO2021170600A1 (en) 2021-09-02
JP2023514443A (ja) 2023-04-05
BR112022016733A2 (pt) 2022-10-11
EP4110777A1 (en) 2023-01-04
AR121403A1 (es) 2022-06-01
US20230130598A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
MX2022010011A (es) Inhibidores de prmt5 novedosos.
MX2025000642A (es) Compuestos macrociclicos para el tratamiento de cancer
MY208632A (en) Novel benzylamino substituted pyridopyrimidinones and derivatives as sos1 inhibitors
CR20240147A (es) Uso de un inhibidor de la ezh2 en la preparación de fármacos para el tratamiento del linfoma de linfocitos t
GEP20094847B (en) Novel phenyl-propargylether derivatives
MX2020011317A (es) Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih.
AU2020231934A8 (en) Compounds useful in HIV therapy
ZA202213152B (en) Novel acid secretion inhibitor and use thereof
TN2019000170A1 (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
EP4613096A3 (en) Antiparasitic compounds
WO2024076951A3 (en) Antiviral prodrugs and formulations thereof
EP4316504A3 (en) Compounds
MX2020000576A (es) Compuestos quimicos.
MX2021008510A (es) Derivados de tiazolopiridina como antagonistas del receptor de adenosina.
MX2021002188A (es) Nuevo derivado de amina heterociclica y composicion farmaceutica que la comprende.
EP4599892A3 (en) Boronic acid derivatives and therapeutic uses thereof
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
MX2024012470A (es) Inhibidores de cinasas dependientes de ciclina 9 (cdk9)
MX2022010413A (es) Compuestos de pirrolopiridina e imidazopiridina antivirales.
MX2024002674A (es) Derivados de tiadiazolona utiles como activadores de ampk.
NZ507452A (en) Hygromycin a derivatives
GEAP202516217A (en) Compounds and compositions as sppl2a inhibitors
WO2020251871A3 (en) Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
PH12023550007A1 (en) Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome
IL159521A0 (en) Tricyclic pyridines for use in treatment of conditions mediated by crf